Effect of Vitamin D Supplementation on the Hemoglobin Level in Chronic Kidney Disease Patients on Hemodialysis: A Systematic Review and Meta-Analysis.

The objective of this study was to evaluate the impact of vitamin D supplementation on hemoglobin levels (Hb) in patients with chronic kidney disease (CKD) undergoing hemodialysis. A systematic search was conducted in electronic databases (PubMed/Medline, Cochrane Library, and Google Scholar) from inception to April 21, 2023. Inclusion criteria were applied to select relevant studies. Statistical analyses were performed using Review Manager 5.4.1. A random-effects model was used to address heterogeneity, and the mean difference (MD) with the corresponding 95% confidence interval (CI) was reported. Ten studies were included in the analysis, comprising seven clinical trials, two randomized clinical trials, and one retrospective observational study. Subgroup analysis was conducted based on the duration of follow-up: 12 weeks, three months, six months, 12 months, 15 months, and 18 months. A significant increase in hemoglobin levels was observed after 12 months (MD = -0.98 [95% CI -1.88, -0.08]; p = 0.03; I2 = 91%) and 18 months (MD = -1.80 [95% CI -2.56, -1.04]; p < 0.00001; I2 = Not applicable). However, there was no statistically significant relationship between vitamin D supplementation and hemoglobin levels at 12 weeks, three months, six months, and 15 months. The pooled analysis demonstrated a significant increase in hemoglobin levels with vitamin D supplementation (MD = -0.61 [95% CI -0.96, -0.26]; p = 0.03; I2 = 60.7%). This analysis highlights the significant role of vitamin D supplementation in improving anemia in patients with CKD undergoing hemodialysis. Vitamin D supplementation was found to significantly increase hemoglobin levels, particularly after 12 months and 18 months of supplementation.

Dulaglutide (Trulicity)-Induced Acute Pancreatitis: A Case Report.

The article discusses the use of dulaglutide (Trulicity) in treating type 2 diabetes mellitus. Dulaglutide is a synthetic analog of glucagon-like peptide (GLP-1) that binds to GLP-1 receptors, enhancing insulin secretion and reducing postprandial glucagon and food intake. Dulaglutide has a longer half-life than GLP-1, making it more clinically useful. The recommended dosage of dulaglutide is 0.75 mg/0.5 mL subcutaneously once weekly, which can be increased as needed for adequate glycemic control. We describe a case of acute pancreatitis in a 37-year-old male with a past medical history of type 2 diabetes mellitus who was admitted for epigastric pain radiating to the back. Lipase level was elevated at 1508, and a computed tomography (CT) scan of the abdomen showed fat stranding around the pancreas consistent with pancreatitis. The patient was on dulaglutide (Trulicity) at 0.75 mg q. weekly for about two years; this dose was increased to 1.5 mg q. weekly two months ago. He developed symptoms of abdominal pain, nausea, and vomiting after receiving the last dose of Trulicity, which was two weeks before he presented to the emergency department as a cause of acute pancreatitis. Dulaglutide use has been known to cause a mild elevation of pancreatic enzyme levels; there have been few reported cases of dulaglutide-associated acute pancreatitis in the literature. The case report highlights the adverse effects of dulaglutide in diabetic patients and the importance of monitoring pancreatic enzyme levels in patients taking dulaglutide.

Postural Control Strategies in Standing With Handrail Support and Active Assistance From Robotic Upright Stand Trainer (RobUST).

In people with severe neuromotor deficits of trunk and lower extremities, regaining balance in standing is often performed in rehabilitation with manual assistance, rigid body supports or by the use of handrails. To investigate and further expand postural control training in standing, we developed a Robotic Upright Stand Trainer (RobUST). In this study, we used RobUST to deliver trunk perturbations while simultaneously providing postural assistive forces on the pelvis in 10 able-bodied adults. Posture control responses with 'pelvic support' was then compared to 'no support' and 'hand supported' standing, with and without assistance from RobUST. We characterize postural imbalance with kinematic displacements and center of pressure (COP) outcomes, such as amplitude and root mean square of the excursions of COP. Surface electromyography (sEMG) was also applied to investigate muscle control. We additionally investigated ground reaction and handrail forces during standing to analyze how postural strategies and muscle mechanisms with 'pelvic support' via RobUST would differ from standing with 'no support' and with the 'handrail support'. Our results show that during perturbations, pelvic assistive support decreased kinematic and COP excursions compared to standing with no support. The pelvic assistance from RobUST showed similar level of COP changes as the use of handrail support but without reducing muscle activity or ground reaction forces. As expected, the maximum level of postural stability was observed when participants used the handrail and received pelvic assistive forces. In conclusion, RobUST demonstrates potential as a training device since it enhances postural balance without significantly removing muscular control mechanisms that are of interest in re-training postural control strategies in standing.

Exploring New Potential Applications for Hand Exoskeletons: Power Grip to Assist Human Standing.

Hand exoskeleton potential applications reach further than grasping or assistance during manipulation. In this paper, we present a preliminary study of how this technology can be applied in order to improve performance during standing to help the user to keep balance under perturbations. Non-impaired users wearing a hand exoskeleton gripping a hand rail were pushed by a cable-driven robot, so that their standing equilibrium was perturbed. The center of pressure, surface electromyography, and interaction force data were recorded in order to assess the performance of users and their postural strategy. The results showed that users could keep their balance with the same outcomes using their bare hands and the hand exoskeleton. However, when wearing the exoskeleton, a higher muscular activity was registered in hand flexor muscles. This is also supported by the grasping force, which shows that users stretched their hand more than expected when wearing the hand exoskeleton. This paper concludes that it is possible that the lack of tactile feedback could lead to over compensation in the grasping. Therefore, the next studies will aim to check whether this effect can be reversed by training users to wear the exoskeleton.

Biomechanical differences during ascent on regular stairs and on a stairmill.

Stair climbing is an intense physical activity and requires large range of motion at the joints, adequate muscle strength, and balance control. A powered stairmill, integrated with a gait rehabilitation device, can potentially be used for training those who have difficulty climbing stairs. In order to assess the effectiveness of such an approach, it is necessary to understand the similarities and differences in walking on regular stairs and on a stairmill. We have conducted an experiment to compare the differences in kinematics and muscle activations during climbing on regular stairs and a stairmill. Twelve subjects participated in this study. They first walked on regular stairs five times and then performed a one-minute continuous walking on a stairmill. The results showed several important differences. During continuous walking on a stairmill, when compared to regular stairs, there was (i) an increase in the percentage of stance phase during a walking cycle, (ii) a higher angle of plantarflexion of the ankle during the transition from stance phase to swing phase, and (iii) a decrease in muscle activation of the tibialis anterior during swing phase. These differences would provide additional insights into the design of future rehabilitation systems and to interpret human data obtained from stairmills.